News & Updates

Abundant sialylated oligosaccharides in breastmilk may impair infant nutrition

15 Jun 2022

Elevated levels of sialylated human milk oligosaccharides (HMO) in mothers’ breastmilk appears to worsen infant nutritional status, reports a Bangladesh study.

Abundant sialylated oligosaccharides in breastmilk may impair infant nutrition

15 Jun 2022

$Trifluridine/tipiracil polypill shows modest clinical activity against refractory ESCC$

Trifluridine/tipiracil polypill shows modest clinical activity against refractory ESCC

15 Jun 2022

The fixed-dose combination of trifluridine/tipiracil may be feasible for use in the treatment of patients with refractory esophageal squamous cell carcinoma (ESCC), with the drug showing modest clinical activity in the phase II ECTAS study.

Trifluridine/tipiracil polypill shows modest clinical activity against refractory ESCC

15 Jun 2022

Rheumatoid arthritis linked to increased risk of out-of-hospital cardiac arrest among women

15 Jun 2022

Out-of-hospital cardiac arrest (OHCA) tend to occur at a higher rate among patients with rheumatoid arthritis (RA), and this risk increase is especially pronounced in women but not observed in men, a study has found.

Rheumatoid arthritis linked to increased risk of out-of-hospital cardiac arrest among women

15 Jun 2022

Original New Drug Application Approvals by US FDA (01 - 15 June 2022)

15 Jun 2022

New drug applications approved by US FDA as of 01 - 15 June 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 June 2022)

15 Jun 2022

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

14 Jun 2022

Drug combinations including venetoclax seem to have a positive impact on health-related quality of life (HRQoL), or at least does not worsen it, in patients with acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy, a recent study has found.

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

14 Jun 2022

‘Digital Twin’ tech reverses type 2 diabetes, fixes metabolic disruptions

14 Jun 2022 by

A novel artificial intelligence platform that integrates multidimensional data to deliver precision nutrition and health recommendations not only helps to induce remission in type 2 diabetes but also to normalize a range of glycaemic and extraglycaemic parameters, as shown in a study presented at the 82nd American Diabetes Association (ADA) Scientific Sessions.

‘Digital Twin’ tech reverses type 2 diabetes, fixes metabolic disruptions

14 Jun 2022

Orthostatic hypotension ups mortality risk in geriatric outpatients

14 Jun 2022

Older outpatients with delayed/prolonged orthostatic hypotension (DPOH) are at higher risk of mortality, reveals a study. The magnitude of both systolic and diastolic OH is also associated with increased death.

Orthostatic hypotension ups mortality risk in geriatric outpatients

14 Jun 2022

Cancer patients report high acceptance of telemedicine

14 Jun 2022 by

Patients with cancer are not averse to telemedicine, reporting satisfaction with their experience, according to a Singapore study. This high acceptance is associated with facilitating conditions such as having necessary resources and perceived improved access.